A Planning Playbook for Opening a New Orthopedic ASC
The ASC market continues its rapid growth. In 2023, roughly 116 new ASCs opened in the U.S., many of which were orthopedic-specific in nature....
This website uses cookies. to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking “Accept & Close”, you consent to our use of cookies. Read our Privacy Policy to learn more.
By: Jay Klarsfeld
Published: 11/5/2008
Today's latest tonsillectomy treatment options employ various energy sources with the same goal in mind: to reduce the amount of heat involved and therefore cause less thermal injury to the surrounding tissue. Be it laser, microdebrider or cold ablation, each new method that has emerged over the past decade or so as an alternative to the traditional dissection methods comes with its own set of marketing claims, proponents, detractors and body of research showing that it's superior to all others. The truth is, in the hands of a capable and experienced surgeon, each can deliver positive results for our patients with minimal bleeding, tissue damage and post-op pain. The question for you then becomes, is it worth the investment?
With CMS's new payment system favoring ENT procedures, ASCs have seen the Medicare reimbursement payment for tonsillectomy increase from $630 last year to $921.41. In the ASC setting, the Medicare reimbursement rate for tonsillectomy is the same regardless of which method the surgeon uses. However, the equipment and disposables involved in some of the newer techniques are more expensive than the instruments used for cold knife and cautery. You'll want to do a thorough cost analysis before you invest in any new devices.
Hard costs
The hard costs — the price of the equipment and disposables you'll need for each treatment method — are the first and perhaps easiest part of the equation to tally. Each technique requires an up-front investment in the base power source for the device, plus the cost of the disposables — wands, blades, saline solution — you'll need for each individual case. Here's a quick look at the basics for each of the most common methods for tonsillectomy.
Soft costs
A side-by-side comparison of the hard costs involved in, say, cold knife and cautery vs. cold ablation or microdebrider vs. laser will only tell you half the story. The second half involves the variable costs and potential benefits of the new technology. While the hard costs are easy to generate by asking for quotes from vendors and manufacturers, these "soft costs" are more nuanced and will require a bit more digging on your part. Some things to consider:
Do your homework
Work closely with the equipment manufacturers and vendors to compile all the information you'll need to make an informed decision. However, the best way to evaluate the economics and feasibility of one of the newer tonsillectomy methods is to see it in action. Ask your vendor for references — is there a facility nearby that uses their device? If so, contact the facility and ask to come in and observe some cases from start to finish. Bring a checklist of the costs you're investigating and fill it out as you observe cases. Talk to the administrators, frontline staff and surgeons at the facility you visit.
When you get back to home base, compare your findings with what you know about the methods for tonsillectomy that are currently used at your facility. Of course, you'll also want your surgeons and staff to trial the new equipment themselves, which will give you a glimpse of how it may affect workflow and staffing on your own turf.
Be wary of claims that a new device will dramatically enhance your surgeons' ability to control bleeding and reduce tissue damage and post-op pain. These claims may well be true, but with a procedure as tried and true as tonsillectomy, the responsibility to control bleeding and minimize pain rests with the surgeon.
Your job is to focus on the quantifiable costs and benefits of investing in a new technology for tonsillectomy and to do a thorough analysis before rushing to purchase the hottest new device on the market.
The ASC market continues its rapid growth. In 2023, roughly 116 new ASCs opened in the U.S., many of which were orthopedic-specific in nature....
In her 24 years as a nurse at Penn Medicine, Connie Croce has seen the evolution from open to laparoscopic to robotic surgery....
Through my decades of researching, testing and helping implement healthcare design solutions, I’ve learned an important lesson: A human-centered and evidence-based...